Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2024-12-12 Investor Presentation
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
113年12月法人說明會簡報 — 178920241212M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation from ScinoPharm Taiwan, Ltd. dated December 12, 2024, containing extensive information about the company's business overview, operational status, financial performance including consolidated income statement, balance sheet, and cash flow statement for the first three quarters of 2024, product pipeline, market data, and Q&A. It includes forward-looking statements and detailed financial data, not just summary highlights. The length is over 10,000 characters, indicating a full report rather than a brief announcement. The content is consistent with an investor presentation focusing on financials, strategy, and market position rather than a formal annual or quarterly report filing. Therefore, the document best fits the category of Investor Presentation (IP).
2024-12-12 Chinese
113年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a schedule and summary of an investor presentation (法人說明會) held online by the company 神隆 on 113/12/12 (Taiwan calendar year). It includes links to PDF files of the presentation materials in Chinese and English, and mentions that the company explained its publicly released Q3 financial figures and operational overview during the meeting. The document is short (756 characters) and serves as an announcement or summary of the investor presentation event rather than the full report or transcript. Therefore, the most appropriate classification is Investor Presentation (IP).
2024-12-12 Chinese
本公司受邀參加元富證券舉辦之線上法人說明會
Regulatory Filings Classification · 90% confidence The document is a short announcement (655 characters) about the company participating in an online investor presentation hosted by a securities firm. It mentions discussing the company's previously released Q3 financial figures and operational overview. There is no detailed financial data or full transcript included, only a notice of the event and a summary of its content. According to the 'Menu vs Meal' rule, this is an announcement of a presentation, not the presentation itself. Therefore, the document fits best as an Investor Presentation (IP) announcement. However, since it is only a brief notice and does not contain the full presentation, it is more appropriate to classify it as a Regulatory Filing (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2024-12-09 Chinese
113年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a short financial disclosure from a listed company, 神隆, providing details about loan balances and endorsement guarantees for the current and previous months. It contains tabular data on financial guarantees and related party endorsements but does not include comprehensive financial statements or detailed analysis. The document length is only 622 characters, indicating it is a brief regulatory disclosure rather than a full report. There is no indication of an earnings release, annual or interim report, or management discussion. The content aligns with a regulatory announcement about financial guarantees and related party transactions, which fits best under Regulatory Filings (RNS) as a general compliance disclosure.
2024-12-09 Chinese
113年11月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a revenue summary report from a listed company, 神隆, showing monthly and cumulative net operating revenue figures with year-over-year comparisons. It includes notes on accounting standards (IFRS) and reporting practices. The document is short (774 characters) and primarily provides summarized financial data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It is also not an announcement of a report publication but a direct data disclosure. Given the nature of the content as a brief financial summary, it best fits the category of Fund Information / Factsheet (FS), which is for brief summaries of key company financials and market info.
2024-12-09 Chinese
113年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, independent directors, and the general manager. It lists share types, quantities held at various times, increases and decreases in holdings, and related notes. This type of detailed insider shareholding information corresponds to notifications about transactions or holdings by company directors and executives. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. Therefore, the document fits the category of Director's Dealing (DIRS).
2024-12-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.